Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC β-nicotinamide mononucleotide, reduced form disodium | 108347-85-9 | 99.6% | 380.20 | C11H15N2Na2O8P | 50 MG
Supplier: Medchemexpress LLC HYW615108B50MG
β-nicotinamide mononucleotide, reduced form disodium (NMNH) is the reduced form of nicotinamide mononucleotide supplied as a disodium salt for research use. It is reported to elevate intracellular NAD+ levels and modulate cellular metabolism in vitro and in vivo. The product is supplied as a light yellow to yellow solid with supporting analytical data (HPLC, NMR, MS) and a certificate of analysis for purity and identity.
- Reduced form of nicotinamide mononucleotide with disodium counterions.
- Reported to increase intracellular NAD+ levels in cellular and animal studies.
- Analytically verified by HPLC, 1H NMR, and mass spectrometry.
- Available in multiple milligram pack sizes to support dosing studies.
- Supplied as a solid with storage recommendations to preserve stability.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?